Company: CMND
Filing Date: 2025-01-22
Form Type: 20-F
Source: 0001213900-25-005490
Chunk: 176

Company: Clearmind Medicine Inc.
Filing Date: 2025-01-22
Form: 20-F
Item: Item 6
Chunk 176
---
ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES

A. Directors and Senior Management

Executive Officers and Directors

The following table sets forth information regarding
our executive officers and directors, including their ages as of October 31, 2024

  Name                      Age      Position                                
 ─────────────────────────────────────────────────────────────────────────────
  Dr. Adi Zuloff-Shani       57      Chief Executive Officer                 
  Alan Rootenberg            72      Chief Financial Officer                 
  Prof. Mark Haden           71      Vice President of Business Development  
  Amitay Weiss               63      Chairman of the Board of Directors      
  Yehonatan Shachar          34      Director                                
  Oz Adler                   39      Director                                
  Asaf Itzhaik               53      Director                                
  Hila Kiron-Revach          44      Director                                

Dr. Adi Zuloff-Shani, Chief Executive Officer

Dr. Adi Zuloff-Shanihas served as our Chief
Executive Officer since July 14, 2021. Dr. Zuloff-Shani has more than 20 years of experience as a research and development executive.
Dr. Zuloff-Shani has also served as the Chief Technologies Officer of SciSparc Ltd. since February 2016. In addition, Dr. Zuloff-Shani
has served as a Member of the Scientific Advisory Board, Save Foods, Inc. (Nasdaq: SVFD) since October 2021, and as Chairman of the board
of directors of ORSUS Therapeutics Limited since November 2021. Prior to joining us, and from 2012 to 2016, Dr. Zuloff-Shani served as
a vice president development at Macrocure Ltd. (Nasdaq: MCUR) where besides leading all research and development activities, she interacted
and was involved with the activities of all departments including clinical, operations, quality assurance, quality control, finance, and
regulatory affairs. Dr. Zuloff-Shani holds a Ph. D. in human biology and immunology from Bar-Ilan University, Israel.

Alan Rootenberg, Chief Financial Officer

Mr. Alan Rootenberg hasserved as our Chief
Financial Officer since June 14, 2022. Mr. Rootenberg also served as our Director from April 15, 2020 until December 2022. Mr. Rootenberg
has served as